| Application no. and date | 18783228.2 (espacenet) (Federated) (European Patent Register), 20180918 | | Patent/reg. no. and date | DK/EP 3684333, 20250305 | | Publication date | 20200729 | | Priority no. and date | US 201762561629 P, 20170921, US 201762564951 P, 20170928 | | EP pub. no. and date |
EP 3684333 20200729 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130, US | | Applicant ref. no. | V489937DK00 | | Inventor | MOORE, Richard Alexander, Jr., 16348 Pinto Ridge Court
San Diego, California 92127, US,
O'BRIEN, Christopher F., 12780 El Camino Real
San Diego, CA 92130, US,
MCCLELLAND, Gregory A., 14029 Via Corsini
San Diego, California 92128, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 47/36 (2006.01) , A61K 47/38 (2006.01) , A61K 9/00 (2006.01) , A61K 9/48 (2006.01) , A61P 25/00 (2006.01) | | Title | VALBENAZIN-FORMULERING MED HØJ DOSIS OG SAMMENSÆTNINGER, FREMGANGSMÅDER OG KITS RELATERET HERTIL | | Int. application no. | US2018051579 | | Int. publication no. | WO2019060322 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
